type sequence filename description exhibit text html head title exhibit title head body bgcolor white style margin margin bottom font size font family time roman align right exhibit style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size font family time roman align center license transfer agreement style margin margin bottom text indent font size font family time roman this license transfer agreement agreement entered into with effect april nbsp effective date between pieris pharmaceutical nevada corporation with place business state street style font size vertical align floor boston pieris pharmaceutical gmbh german company with place business lise meitner strasse freising germany collectively together with their affiliate pieris enumeral biomedical holding delaware corporation with place business cambridgepark drive suite cambridge together with affiliate enumeral style margin margin bottom text indent font size font family time roman whereas enumeral posse proprietary technology intellectual property right related certain antibody style margin margin bottom text indent font size font family time roman whereas pieris wish obtain more such antibody development commercialization license intellectual property related such antibody style margin margin bottom text indent font size font family time roman whereas enumeral willing provide such antibody license such intellectual property pieris development commercialization novel compound comprising fusion protein based such antibody oncology style margin margin bottom text indent font size font family time roman therefore consideration mutual covenant promise contained this agreement other good valuable consideration receipt sufficiency which hereby acknowledged party hereto intending legally bound hereby agree follows style margin margin bottom font size font family time roman definition used this agreement following term whether used singular plural shall have following meaning style margin margin bottom margin left font size font family time roman affiliate term affiliate shall mean individual corporation association other business entity that directly indirectly control controlled under common control with party question used this definition affiliate only term control shall mean direct indirect ownership more than fifty percent stock having right vote director thereof ability otherwise control management corporation other business entity whether through ownership voting security contract resolution regulation otherwise style margin margin bottom margin left font size font family time roman anticalin style font size vertical align term anticalin style font size vertical align shall mean whether nucleic acid protein form mutein lipocalin term mutein shall mean protein arising result mutation recombinant procedure style margin margin bottom margin left font size font family time roman commercially reasonable effort term commercially reasonable effort shall mean such level effort required carry such obligation manner consistent with effort that pharmaceutical company comparable with pieris would devote same stage development commercialization applicable internally developed therapeutic product similar area with similar market potential similar stage their product life taking into account existence other competitive product market place under development proprietary position product regulatory structure style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center portion exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule security exchange amended style margin margin bottom font size font family time roman align center page style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom margin left font size font family time roman involved intellectual property consideration anticipated profitability product other relevant factor understood that such product potential change from time time based upon changing scientific business marketing return investment consideration avoidance doubt commercially reasonably effort require pieris seek market therapeutic product every country seek obtain regulatory approval every country every potential indication style margin margin bottom margin left font size font family time roman confidential information term confidential information mean nonpublic information disclosed oral written electronic other form otherwise learned party receiving such information recipient including limited information regarding activity party disclosing such information discloser such research development preclinical clinical program data result pharmaceutical biologic candidate product invention work authorship trade secret process conception formula patent patent application license business product marketing sale scientific technical strategy program result including cost price supplier manufacturer customer market data personnel consultant other confidential matter related discloser pieris confidential information shall specifically include public sequence information provided pieris enumeral anticalin style font size vertical align protein lipocalin muteins therapeutic diagnostic information anticalin style font size vertical align protein lipocalin muteins including therapeutic drug program derived therefrom information disclosed pieris enumeral relating target molecule anticalin style font size vertical align protein provided however that pieris shall disclose information related target molecule anticalin style font size vertical align enumeral without prior written consent enumeral enumeral confidential information shall confidential information disclosed enumeral pieris confidential information shall confidential information disclosed pieris style margin margin bottom margin left font size font family time roman calendar quarter term calendar quarter mean each three month period year commencing with january nbsp such year style margin margin bottom margin left font size font family time roman definitive agreement term definitive agreement shall have meaning forth section nbsp style margin margin bottom margin left font size font family time roman developed term developed shall have meaning forth section nbsp style margin margin bottom margin left font size font family time roman effective date term effective date shall have meaning forth first paragraph agreement style margin margin bottom margin left font size font family time roman enumeral term enumeral shall mean nbsp know enumeral owns control with respect first antibody effective date nbsp know enumeral owns control with respect subsequent antibody option exercise date defined section nbsp nbsp patent right enumeral owns control claiming first antibody upon option exercise date subsequent antibody including without limitation patent issuing such patent application substitution extension supplementary protection certificate reissue reexamination renewal division continuation continuation part with respect thereto during term case each clause nbsp nbsp only such know patent right relate first antibody subsequent antibody method using administrating manufacturing formulating said first subsequent antibody useful necessary pieris develop commercialize product under this agreement patent right effective date listed exhibit style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center portion exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule security exchange amended style margin margin bottom font size font family time roman align center page style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom margin left font size font family time roman exclusive field term exclusive field shall mean within field that employ first antibody subsequent antibody fused with linked more anticalin style font size vertical align protein style margin margin bottom margin left font size font family time roman field term field shall mean therapeutic prophylactic diagnostic palliative diagnosis treatment cancer provided that subject section nbsp diagnostic shall limited product shall include service until definitive agreement reached which party intend will provide inclusion diagnostic service within field style margin margin bottom margin left font size font family time roman first antibody term first antibody shall mean individually collectively antibody against described exhibit style margin margin bottom margin left font size font family time roman study term study mean with respect product study conducted accordance with purpose assessing efficacy safety onset severity duration toxic effect their dose dependency establish profile sufficient support filing investigational drug application style margin margin bottom margin left font size font family time roman good laboratory practice term good laboratory practice mean then current good laboratory practice standard promulgated endorsed food drug administration case other country territory comparable regulatory standard promulgated endorsed that country including those procedure expressed contemplated regulatory filing style margin margin bottom margin left font size font family time roman infringed patent term infringed patent shall mean issued unexpired patent nbsp that been abandoned held invalid revoked held rendered unenforceable lost through interference nbsp claim which would infringed pieris making using selling offering sale importing first antibody subsequent antibody portion component thereof case style margin margin bottom margin left font size font family time roman know term know shall mean data knowledge information including chemical manufacturing data toxicological data pharmacological data preclinical data formulation specification quality control testing data that necessary useful discovery manufacture development commercialization product existing date this agreement avoidance doubt know include antibody screening technology licensed enumeral from massachusetts institute technology further require enumeral provide sample first antibody party will agree writing whether what extent sample subsequent antibody required connection with definitive agreement style margin margin bottom margin left font size font family time roman maintenance term maintenance shall have meaning forth section nbsp style margin margin bottom margin left font size font family time roman major market term major market mean territory north america european union japan style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center portion exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule security exchange amended style margin margin bottom font size font family time roman align center page style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom margin left font size font family time roman marketing authorization term marketing authorization shall mean shall mean approval license registration authorization including pricing approval necessary sale product market country territory granted competent regulatory authority style margin margin bottom margin left font size font family time roman modification term modification mean alteration mutation derivative first antibody subsequent antibody invented conceived reduced practice behalf pieris affiliate sublicensees avoidance doubt modification shall mean first antibody subsequent antibody fused with linked anticalin style margin margin bottom margin left font size font family time roman sale term sale shall mean shall mean product particular period nbsp style margin margin bottom margin left font size font family time roman gross amount invoiced pieris sale product third party field territory excluding transaction transferring product pieris affiliate sublicensee distributor agent resale following item style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign customary trade prompt payment quantity cash discount extent actually allowed taken table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign amount repaid credited reason rejection recall return table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign extent separately stated purchase order invoice other document sale duty tariff other governmental charge levied production sale transportation delivery product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign outbound transportation cost prepaid allowed cost insurance transit table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign discount rebate other payment required made under medicaid medicare other governmental special medical assistance program extent actually allowed taken table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign amount written reason uncollectible debt exceed sale calendar year table style margin margin bottom margin left font size font family time roman other deduction shall made commission paid individual whether they with independent sale agency regularly employed pieris payroll cost collection product shall considered sold ninety nbsp after billing invoicing upon receipt payment whichever come first provided however that product actually shipped customer style margin margin bottom margin left font size font family time roman sublicensees sale amount reported calendar quarterly basis pieris accordance with sublicensee contractual term their then currently used accounting standard provided however that such accounting standard consistent with nbsp gaap ifrs such other internationally recognized accounting standard agreed party style margin margin bottom margin left font size font family time roman party term party shall mean pieris enumeral case party shall mean pieris enumeral collectively style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center portion exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule security exchange amended style margin margin bottom font size font family time roman align center page style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom margin left font size font family time roman patent right term patent right shall mean right under patent patent application country territory including patent issuing such patent application further including substitution extension supplementary protection certificate reissue reexamination renewal division continuation continuation part foregoing style margin margin bottom margin left font size font family time roman phase clinical trial term phase clinical trial mean human clinical trial product country that would satisfy requirement style margin margin bottom margin left font size font family time roman phase clinical trial term phase clinical trial mean human clinical trial conducted country that would satisfy requirement intended explore more dose response duration effect generate initial evidence clinical activity safety product target patient population style margin margin bottom margin left font size font family time roman phase clinical trial term phase clinical trial mean clinical trial extended human patient population designed obtain data determining efficacy safety product support regulatory approval proposed therapeutic indication more fully defined successor regulation equivalent foreign country style margin margin bottom margin left font size font family time roman product term product shall mean fusion protein formulation containing such fusion protein that constitutes first antibody subsequent antibody modification which first antibody subsequent antibody component portion thereof modification fused with linked least anticalin style font size vertical align avoidance doubt product also include first antibody subsequent antibody modification that fused with linked anticalin style font size vertical align more additional protein term product expressly includes multi specific fusion protein against least unlimited number target style margin margin bottom margin left font size font family time roman royalty term term royalty term shall mean with respect product given country period time commencing date first commercial sale product such country ending later date that nbsp year after date first commercial sale product such country nbsp expiration last expire lapse valid claim patent right owned enumeral filed effective date such country covering import offering sale sale product style margin margin bottom margin left font size font family time roman sublicensee term sublicensee shall mean entity which pieris licensed right through multiple tier pursuant this agreement style margin margin bottom margin left font size font family time roman subsequent antibody term subsequent antibody shall mean antibody antibody which principally specifically bind target site known owned enumeral other than first antibody that licensed pieris pursuant section nbsp will more specifically described exhibit included definitive agreement style margin margin bottom margin left font size font family time roman territory term territory shall mean country world style margin margin bottom margin left font size font family time roman term term term shall have meaning forth section nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center portion exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule security exchange amended style margin margin bottom font size font family time roman align center page style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom margin left font size font family time roman third party term third party shall mean party other than pieris enumeral style margin margin bottom font size font family time roman grant license transfer style margin margin bottom margin left font size font family time roman license pieris subject term condition hereof enumeral hereby grant pieris during term currently effective royalty bearing exclusive except exclusive field right license including right sublicense through multiple tier under enumeral research have researched develop have developed register have registered have used make have made import have imported export have exported market have marketed distribute have distributed sold have sold product field territory style margin margin bottom margin left font size font family time roman transfer within nbsp payment initial enumeral shall provide pieris full sequence information first antibody relevant know related first antibody described definition enumeral style margin margin bottom margin left font size font family time roman exclusive field until completion royalty payment under section nbsp enumeral hereby covenant agrees shall practice exclusive field avoidance doubt during such period time enumeral shall conduct research development effort exclusive field shall file patent application claiming invention exclusive field assist third party doing enumeral further shall license enumeral exclusive field party other than pieris shall applicable include license other agreement restriction prohibiting first antibody subsequent antibody exclusive field enumeral shall remain responsible enforcement this section shall liable breach this section licensee sublicensee enumeral that violate this section notwithstanding foregoing nothing herein shall deemed prevent third party from acquiring enumeral even engaged research development sale lipocalins provided such lipocalins with enumeral during period herein style margin margin bottom margin left font size font family time roman sublicenses pieris shall have right sublicense subcontract through multiple tier without prior consent enumeral provided however that event such sublicensing nbsp such sublicensees will subject least same confidentiality diligence obligation pieris hereunder nbsp pieris will remain liable term condition this agreement breach sublicensee these term nbsp pieris promptly notifies enumeral sublicense along with identity applicable sublicensee nbsp sublicenses shall writing pieris shall sublicense first antibody subsequent antibody modification unless part product style margin margin bottom font size font family time roman diligence style margin margin bottom margin left font size font family time roman diligence during term agreement pieris shall commercially reasonable effort develop least product sale least each major market style margin margin bottom font size font family time roman payment style margin margin bottom margin left font size font family time roman initial pieris shall enumeral initial which shall upon execution this agreement paid within fifteen nbsp effective date style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center portion exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule security exchange amended style margin margin bottom font size font family time roman align center page style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom margin left font size font family time roman maintenance nbsp pieris shall enumeral maintenance maintenance event that pieris this maintenance agreement shall terminate license under section nbsp shall automatically terminate avoidance doubt payment maintenance shall deemed breach this agreement other than initial forth section nbsp pieris shall have further financial obligation enumeral simultaneous with payment maintenance pieris party shall execute full license transfer agreement including customary contractual term that forth right obligation party definitive agreement superseding this agreement which party hereby agree diligently negotiate good faith upon execution agreement party fail agree definitive agreement date payment maintenance specified this section pieris elect upon sole discretion maintenance this agreement shall continue govern right obligation party avoidance doubt enumeral shall have right terminate this agreement failure execute definitive agreement moreover failure execute definitive agreement shall affect pieris enumeral right under this agreement style margin margin bottom margin left font size font family time roman development milestone payment with respect each first antibody subsequent antibody pieris shall following milestone payment enumeral later nbsp occurrence product product achieve each following event nbsp occurrence following event corresponding milestone payment with respect payment from sublicensee pieris style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width valign bottom width style font family time roman font size valign bottom nowrap style margin margin bottom border bottom solid width font size font family time roman development event valign bottom nbsp nbsp valign bottom align center style border bottom solid nbsp product nbsp indication valign bottom nbsp nbsp valign bottom align center style border bottom solid nbsp product nbsp indication valign bottom nbsp nbsp valign bottom align center style border bottom solid nbsp product nbsp indication bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center nbsp valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center nbsp valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center nbsp valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center nbsp valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center nbsp valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center nbsp valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center nbsp valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center nbsp valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center nbsp valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman total valign bottom nbsp nbsp valign bottom align center nbsp valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman grand total valign bottom nbsp nbsp valign bottom colspan thirty seven million seven hundred fifty thousand dollar table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center portion exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule security exchange amended style margin margin bottom font size font family time roman align center page style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom margin left font size font family time roman avoidance doubt event shall milestone payment paid pieris under this section nbsp exceed thirty seven million seven hundred fifty thousand dollar first antibody thirty seven million seven hundred fifty thousand dollar subsequent antibody style margin margin bottom margin left font size font family time roman sale milestone payment with respect each first antibody subsequent antibody pieris shall following sale milestone payment enumeral later nbsp occurrence product achieve each following event nbsp occurrence following event corresponding milestone payment with respect payment from sublicensee pieris style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width style font family time roman font size valign bottom nowrap style margin margin bottom border bottom solid width font size font family time roman sale threshold valign bottom nbsp nbsp valign bottom align center style border bottom solid product valign bottom nbsp nbsp valign bottom align center style border bottom solid product bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman style font size vertical align year with sale valign bottom nbsp nbsp valign bottom nowrap align center valign bottom nbsp nbsp valign bottom nowrap align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman style font size vertical align year with sale valign bottom nbsp nbsp valign bottom nowrap align center valign bottom nbsp nbsp valign bottom nowrap align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman style font size vertical align year with sale valign bottom nbsp nbsp valign bottom nowrap align center valign bottom nbsp nbsp valign bottom nowrap align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman total valign bottom nbsp nbsp valign bottom nowrap align center valign bottom nbsp nbsp valign bottom nowrap align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman grand total valign bottom nbsp nbsp valign bottom colspan nbsp sixty nbsp seven nbsp million five hundred thousand dollar table style margin margin bottom margin left font size font family time roman avoidance doubt event shall milestone payment paid pieris under this section nbsp exceed sixty seven million five hundred thousand dollar first antibody sixty seven million five hundred thousand dollar subsequent antibody sale shall calculated worldwide basis style margin margin bottom margin left font size font family time roman royalty payment during royalty term pieris shall following royalty payment enumeral within time forth section nbsp style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nowrap style margin margin bottom border bottom solid width font size font family time roman royalty tier valign bottom nbsp nbsp valign bottom align center style border bottom solid royalty nbsp rate nbsp nbsp incremental nbsp annual nbsp nbsp sale bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman sale valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman sale valign bottom nbsp nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman sale valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman sale valign bottom nbsp nbsp valign bottom align center table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center portion exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule security exchange amended style margin margin bottom font size font family time roman align center page style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom margin left font size font family time roman royalty payment under this section nbsp shall incremental calculated paid product product worldwide basis avoidance doubt royalty term shall country country basis royalty under this section nbsp shall paid sale country where royalty term expired style margin margin bottom margin left font size font family time roman royalty payment reduction style margin margin bottom margin left font size font family time roman event that pieris required enter into license other agreement license royalty third party infringed patent royalty payment described section nbsp shall reduced amount such third party payment fifty percent nbsp royalty payment each calendar year avoidance doubt event shall royalty rate under section nbsp reduced more than fifty percent nbsp period style margin margin bottom margin left font size font family time roman event that valid patent claim issue from enumeral covering first antibody subsequent antibody country that claim enumeral covering first antibody subsequent antibody subsequently invalidated country then royalty shall reduced duration royalty term country country basis avoidance doubt event shall royalty rate under section nbsp reduced more than period style margin margin bottom margin left font size font family time roman subsequent antibody payment enumeral hereby grant pieris exclusive option period ending month after effective date license nbsp subsequent antibody owned controlled enumeral order develop commercialize more additional product within field such subsequent antibody shall identified pieris enumeral writing later than time maintenance paid pursuant section nbsp pieris wish exercise option pieris shall enumeral within pieris written notice enumeral election exercise option option exercise date described this section within such payment enumeral shall provide pieris full sequence information related know subsequent antibody useful necessary pieris develop commercialize product under this agreement event that pieris make such election definitive agreement this agreement event that there definitive agreement shall apply subsequent antibody mutatis mutandis subsequent antibody first antibody meaning term shall apply addition application term first antibody style margin margin bottom margin left font size font family time roman diagnostic service payment product used connection with diagnostic service party shall negotiate good faith payment structure such service definitive agreement pieris enumeral such payment structure shall view enumeral third party obligation massachusetts institute technology shall take into account party desire maintain same overall economic structure forth this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center portion exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule security exchange amended style margin margin bottom font size font family time roman align center page style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom margin left font size font family time roman development commercialization pieris shall solely responsible development commercialization product under this agreement shall have obligation consult with enumeral regarding such development commercialization activity style margin margin bottom font size font family time roman report payment record style margin margin bottom margin left font size font family time roman report payment style margin margin bottom margin left font size font family time roman report within after conclusion each calendar quarter commencing with first calendar quarter which sale generated pieris shall deliver enumeral report containing following information each instance product product basis style margin margin bottom margin left font size font family time roman amount product sold leased otherwise transferred performed pieris affiliate sublicensees applicable calendar quarter style margin margin bottom margin left font size font family time roman gross amount billed invoiced product sold leased otherwise transferred performed pieris affiliate sublicensees during applicable calendar quarter style margin margin bottom margin left font size font family time roman calculation sale applicable calendar quarter style margin margin bottom margin left font size font family time roman total amount payable enumeral dollar sale applicable calendar quarter together with exchange rate used conversion style margin margin bottom margin left font size font family time roman each such quarterly report shall certified behalf pieris chief financial officer true correct complete material respect amount enumeral particular calendar quarter report shall state extent that information described this section nbsp received from sublicensee pieris shall required provide such information enumeral shall take action obtain such information style margin margin bottom margin left font size font family time roman payment within later nbsp after each calendar quarter nbsp after each quarter with respect payment from sublicensee pieris shall enumeral amount with respect sale applicable calendar quarter style margin margin bottom margin left font size font family time roman payment currency payment under this agreement will paid dollar conversion foreign currency dollar will made conversion rate existing united state reported wall street journal last working applicable calendar quarter such payment will without deduction exchange collection other charge style margin margin bottom margin left font size font family time roman record pieris shall maintain shall applicable cause affiliate maintain complete accurate record product that sold leased transferred under this agreement amount payable enumeral relation such product which record shall contain sufficient information permit enumeral confirm accuracy report notification delivered enumeral under section nbsp pieris affiliate applicable shall retain such record relating given calendar quarter least style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center portion exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule security exchange amended style margin margin bottom font size font family time roman align center page style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom margin left font size font family time roman year after conclusion that calendar quarter during which time enumeral will have right expense cause independent certified public accountant inspect such record pieris during normal business hour purpose verifying accuracy report payment delivered under this agreement pieris compliance with term hereof such accountant other auditor applicable shall disclose enumeral information other than information relating accuracy report payment delivered under this agreement party shall reconcile underpayment overpayment within after accountant delivers result audit audit performed under this section nbsp reveals underpayment excess calendar year pieris shall reimburse enumeral amount incurred connection with such audit avoidance doubt enumeral shall have right audit inspect sublicensee directly audit inspect applicable material received from sublicensee possession pieris pieris however shall audit sublicensees require royalty milestone report connection with sublicense enumeral exercise right under this section nbsp only once every month period only with reasonable prior notice style margin margin bottom margin left font size font family time roman late payment payment pieris that paid before date such payment under this agreement will bear interest percent month interest will accrue beginning first following date payment will compounded quarterly payment such interest pieris shall limit enumeral right exercise other remedy enumeral have consequence lateness payment style margin margin bottom margin left font size font family time roman payment method each payment enumeral under this agreement shall paid check wire transfer fund enumeral account accordance with written instruction provided enumeral made wire transfer such payment shall marked refer this agreement style margin margin bottom margin left font size font family time roman withholding similar pieris required withhold amount payable hereunder enumeral applicable country such amount will deducted from payment made pieris remitted appropriate taxing authority benefit enumeral pieris will withhold only such amount required withheld applicable country from which payment being made pieris shall submit enumeral original remittance voucher official receipt evidencing payment corresponding with applicable royalty report pieris will cooperate with enumeral provide such information record enumeral require connection with application enumeral authority country including attempt obtain exemption credit withholding paid country style margin margin bottom font size font family time roman intellectual property style margin margin bottom margin left font size font family time roman product intellectual property pieris shall have right file patent application invention developed direction under sponsorship pieris including limited invention conceived reduced practice pieris employee contractor consultant sublicenses related product material process other intellectual property generated under this agreement including manufacture style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center portion exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule security exchange amended style margin margin bottom font size font family time roman align center page style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom margin left font size font family time roman formulation thereof developed avoidance doubt developed includes limited directed sequence product formulation method method manufacture thereof event termination this agreement pieris shall continue such intellectual property style margin margin bottom margin left font size font family time roman license enumeral developed that fall outside scope product developed related product including limited product formulation method product method manufacture product target based claim including product exclusive field collectively grantback pieris hereby grant enumeral claim claim basis royalty free fully paid exclusive license with right sublicense such claim from grantback sake clarity nothing license granted under this section nbsp shall affect scope exclusive field covenant enumeral under section nbsp without limiting foregoing pieris file patent application obtains patent containing claim claim directed modification other than modification fused with linked anticalin whether singly more many claim under broader patent then such claim case shall part grantback licensed hereunder including limited composition matter method manufacture vector host cell related thereto style margin margin bottom font size font family time roman liability indemnification style margin margin bottom margin left font size font family time roman indemnity enumeral enumeral shall indemnify defend hold harmless pieris affiliate their respective director officer employee agent their respective successor heir assigns collectively pieris indemnitees from against liability damage loss expense including reasonable attorney expense litigation collectively loss nbsp incurred imposed upon pieris indemnitees them result claim whitehead institute biomedical research general hospital corporation massachusetts general hospital president fellow harvard college howard hughes medical institute collectively agreement party connection with agreement between agreement party enumeral nbsp incurred imposed upon pieris indemnitees them direct result claim suit action demand judgment third party arising resulting from breach representation warranty hereunder collectively pieris indemnity claim style margin margin bottom margin left font size font family time roman indemnity pieris pieris shall indemnify defend hold harmless enumeral affiliate their respective director officer employee agent their respective successor heir assigns collectively enumeral indemnitees against loss incurred imposed upon enumeral indemnitees them direct result claim suit action demand judgment third party arising resulting from nbsp development commercialization manufacture product either before after receipt nbsp breach representation warranty hereunder collectively enumeral indemnity claim style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center portion exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule security exchange amended style margin margin bottom font size font family time roman align center page style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom margin left font size font family time roman condition indemnification person seeking recovery under this section nbsp indemnified party respect claim shall give prompt notice such claim party from whom indemnification sought indemnifying party provided that indemnifying party contesting obligation under this section nbsp shall permit indemnifying party control litigation relating such claim disposition such claim further provided that indemnifying party shall nbsp reasonably good faith with respect matter relating settlement disposition such claim settlement disposition relates such indemnified party nbsp settle otherwise resolve such claim without prior written consent such indemnified party which consent shall unreasonably withheld conditioned delayed each indemnified party shall cooperate with indemnifying party defense such claim reasonable respect shall have right present person through counsel legal proceeding with respect such claim indemnifying party assume conduct defense claim provided above nbsp indemnified party defend against consent entry judgment enter into settlement with respect such claim manner indemnified party deem reasonably appropriate indemnified party need consult with obtain consent from indemnifying party connection therewith nbsp indemnifying party shall remain responsible indemnify indemnified party provided this section nbsp style margin margin bottom margin left font size font family time roman insurance each party shall procure maintain insurance including applicable pieris affiliate product liability insurance shall self insure each case manner adequate cover obligation under this agreement consistent with normal business practice prudent company similarly situated time during term period five nbsp year thereafter each party shall procure insurance self insure expense understood that such insurance shall construed create limit either party liability with respect indemnification obligation under this section nbsp each party shall provide other party with written evidence such insurance self insurance upon request each party shall provide other party with prompt written notice prior cancellation renewal material change such insurance style margin margin bottom font size font family time roman confidentiality style margin margin bottom margin left font size font family time roman treatment confidential information with respect confidential information discloser recipient agrees nbsp such confidential information solely contemplated this agreement including pieris development commercialization more product other purpose nbsp hold such confidential information confidence disclose such confidential information others except employee consultant representative require confidential information order carry purpose subject binding obligation confidentiality restricted least protective those this agreement nbsp protect confidentiality such confidential information using least same level effort measure used protect valuable confidential information least commercially reasonable effort measure nbsp notify discloser promptly practicable unauthorized disclosure such confidential information which recipient becomes aware style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center portion exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule security exchange amended style margin margin bottom font size font family time roman align center page style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom margin left font size font family time roman exception confidential treatment obligation section nbsp shall apply confidential information that nbsp recipient knew before learning under this agreement demonstrated written record predating date learned under this agreement nbsp becomes future publicly available except omission recipient nbsp third party discloses recipient without restriction disclosure breach confidentiality obligation which such third party subject nbsp recipient independently develops without reference confidential information demonstrated recipient written record contemporaneous with such development style margin margin bottom margin left font size font family time roman required disclosure notwithstanding section nbsp recipient disclose discloser confidential information extent person entity required under applicable governmental rule regulation order provided that recipient nbsp first give prompt written notice such disclosure requirement discloser enable discloser seek limitation exemption from such disclosure requirement nbsp reasonably cooperates discloser request such effort discloser style margin margin bottom margin left font size font family time roman ownership confidential information subject section nbsp discloser retains right title interest confidential information style margin margin bottom margin left font size font family time roman publicity upon execution this agreement party file form statement attached exhibit disclosure existence term this agreement made either party party shall name trademark trade name logo other party employee publicity promotion news release disclosure relating this agreement subject matter without prior express written permission other party except otherwise forth herein extent required regulation including limited federal state security which prior written permission required with respect filing this agreement with security exchange commission each party will provide other party with reasonable advance notice copy portion such proposed filing which agreement directly relates each party provide comment request regarding proposed confidential treatment agreement term condition agreement case other party will consider reasonable comment request made with respect such filing provided that such comment request consistent with applicable regulation party will agree propose redaction same information confidential treatment application this agreement applicable definitive agreement notwithstanding this section nbsp each party shall permitted issue later date public filing presentation press release regarding this agreement definitive agreement that contain information from party form statement attached exhibit applicable enumeral press release attached exhibit style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center portion exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule security exchange amended style margin margin bottom font size font family time roman align center page style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom margin left font size font family time roman ownership information data information generated pieris using enumeral confidential information including limited data information related product shall sole property pieris pieris shall have unlimited right disclose such information information related product whether generated using enumeral confidential information otherwise shall sole property pieris pieris shall have obligation disclose information described this section nbsp enumeral style margin margin bottom margin left font size font family time roman third party disclosure notwithstanding anything this section nbsp either party share existence term this agreement enumeral confidential information related first antibody with third party under obligation confidentiality least restrictive those this agreement defined below without prior consent other party this includes right provide such information potential investor order facilitate investment financing connection with development more product pieris event each party remains subject obligation forth herein style margin margin bottom margin left font size font family time roman prior agreement party have previously entered into mutual confidential disclosure agreement dated october nbsp material transfer disclosure agreement dated january nbsp confidential information under this agreement includes public information disclosed connection with extent that there inconsistency this agreement shall supersede style margin margin bottom font size font family time roman term termination style margin margin bottom margin left font size font family time roman term term this agreement shall from effective date absence early termination provided below shall expire upon expiration last expire patent claim from enumeral covering import offering sale sale product style margin margin bottom margin left font size font family time roman termination pieris pieris terminate this agreement time upon thirty nbsp notice style margin margin bottom margin left font size font family time roman termination enumeral enumeral terminate this agreement pieris breach material obligation under this agreement fails cure such breach within sixty nbsp thirty nbsp with respect breach payment obligation pieris following receipt written notice thereof from enumeral such breach curable within aforesaid period provided however that without limiting application section nbsp this agreement there dispute between party connection with such termination under this section nbsp shall subject dispute resolution procedure section nbsp style margin margin bottom margin left font size font family time roman termination insolvency party shall have right terminate this agreement entirety upon immediate written notice other party nbsp applies consent appointment taking possession receiver custodian trustee liquidator itself substantial part property nbsp make general assignment benefit creditor nbsp commences voluntary case under bankruptcy code defined below country nbsp fails controvert timely appropriate manner acquiesce writing petition filed against involuntary case under bankruptcy code country nbsp take corporate action purpose effecting style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center portion exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule security exchange amended style margin margin bottom font size font family time roman align center page style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom margin left font size font family time roman foregoing nbsp order relief against entered involuntary case under bankruptcy code country nbsp through nbsp above application assignment commencement filing corporate action continues unstayed otherwise discharged withdrawn before period sixty nbsp style margin margin bottom margin left font size font family time roman effect termination event termination this agreement nbsp pieris retain shall required provide enumeral with information material related product created developed connection with this agreement including material described section nbsp nbsp license enumeral shall terminate until definitive agreement reached more distinctly forth party right post termination pieris shall longer have right develop commercialize product style margin margin bottom margin left font size font family time roman survival following section shall survive termination expiration this agreement extent payment will earned after termination extent payment will earned after termination style margin margin bottom font size font family time roman representation warranty style margin margin bottom margin left font size font family time roman notice infringement enumeral warrant represents that received cease desist letter otherwise been informed third party that infringing intellectual property related first antibody that would otherwise adversely impair pieris ability develop commercialize product under this agreement style margin margin bottom margin left font size font family time roman conflicting obligation enumeral warrant represents that ability enter into this agreement that agreement with third party including conflict with this agreement style margin margin bottom margin left font size font family time roman mutual representation warranty pieris enumeral each represents warrant other effective date except otherwise noted follows style margin margin bottom margin left font size font family time roman organization corporation company duly organized validly existing good standing under jurisdiction organization requisite power authority corporate otherwise execute deliver perform this agreement style margin margin bottom margin left font size font family time roman authorization execution delivery this agreement performance transaction contemplated hereby have been duly authorized necessary corporate company action will violate nbsp such party certificate incorporation bylaw equivalent organizational document nbsp agreement instrument contractual obligation which such party bound material respect nbsp requirement applicable nbsp order writ judgment injunction decree determination award court governmental agency presently effect applicable such party style margin margin bottom margin left font size font family time roman binding agreement this agreement legal valid binding obligation such party enforceable against accordance with term condition style margin margin bottom margin left font size font family time roman inconsistent obligation under obligation contractual otherwise person that conflict with inconsistent respect with term this agreement that would impede diligent complete fulfillment obligation hereunder style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center portion exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule security exchange amended style margin margin bottom font size font family time roman align center page style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom margin left font size font family time roman compliance with during term will comply will ensure that affiliate comply with local state federal international regulation material respect connection with obligation hereunder including with respect pieris those regulation relating development manufacture sale importation product style margin margin bottom font size font family time roman miscellaneous style margin margin bottom margin left font size font family time roman bankruptcy license extent applicable right granted under pursuant this agreement enumeral pieris shall otherwise deemed purpose section nbsp title united state code bankruptcy code license right intellectual property defined under section nbsp bankruptcy code party agree that pieris licensee such right under this agreement shall retain fully exercise right election under bankruptcy code style margin margin bottom margin left font size font family time roman limitation damage other than representation warranty forth herein pieris enumeral disclaim other warranty whether express implied with respect each their obligation hereunder including whether more product successfully developed marketed event shall either pieris enumeral liable special indirect incidental consequential damage arising this agreement based contract tort other legal theory style margin margin bottom margin left font size font family time roman dispute resolution event controversy claim counterclaim arising relation this agreement party will first attempt resolve such controversy claim through good faith negotiation between pieris enumeral period than thirty nbsp following written notification such controversy claim other party such controversy claim resolved mean such negotiation during such period then will finally settled under rule arbitration international chamber commerce more arbitrator appointed accordance with such rule place arbitration will york language used arbitration proceeding will english notwithstanding foregoing nothing shall prevent either party from seeking injunctive other similar equitable relief venue permitted section nbsp style margin margin bottom margin left font size font family time roman governing this agreement shall governed construed accordance with york without reference conflict principle subject section nbsp party consent exclusive jurisdiction state federal court york event that there dispute related this agreement style margin margin bottom margin left font size font family time roman assignment this agreement assigned transferred either party without prior written consent other party notwithstanding foregoing either party shall have right assign this agreement affiliate third party connection with nbsp acquisition consolidation with merger into other corporation other entity person nbsp corporate reorganization wherein there change control nbsp sale business which this agreement related provided however that such transaction assignee expressly obligates itself style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center portion exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule security exchange amended style margin margin bottom font size font family time roman align center page style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom margin left font size font family time roman written instrument delivered assigning party this agreement before date closing such transaction fully perform obligation assigning party under this agreement nbsp this right assignment shall likewise available assignee same manner assigning party subsequent assignee like manner provided that each instance assignment assignee provides writing specified above assigning party this agreement prior date closing such transaction style margin margin bottom margin left font size font family time roman entire understanding this agreement contains entire understanding between party hereto with respect within subject matter supersedes prior agreement understanding arrangement whether written oral style margin margin bottom margin left font size font family time roman unenforceable provision severability provision this agreement held void unenforceable then such void unenforceable provision shall replaced valid enforceable provision that will achieve possible economic business intention party however remainder this agreement will remain full force effect provided that material interest party affected party would presumably have concluded this agreement without unenforceable provision style margin margin bottom margin left font size font family time roman waiver amendment this agreement amended modified superseded canceled term this agreement waived only written instrument executed each party case waiver party party waiving compliance delay failure either party time time require performance exercise right arising provision shall manner affect right later time enforce same waiver party particular provision right shall writing shall particular matter applicable particular period time shall signed such party single partial exercise right power privilege will preclude other further exercise such right power privilege exercise other right power privilege waiver either party condition breach term contained this agreement whether conduct otherwise more instance shall deemed considered further continuing waiver such condition breach such term other term this agreement except expressly forth this agreement right remedy available party whether under this agreement afforded applicable otherwise will cumulative alternative other right remedy that available such party style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center portion exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule security exchange amended style margin margin bottom font size font family time roman align center page style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman witness whereof party hereto have executed this agreement effective date style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width valign bottom width width valign bottom width width style font family time roman font size valign colspan pieris pharmaceutical valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign colspan enumeral biomedical holding style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom nbsp nbsp valign style margin margin bottom border bottom solid font size font family time roman stephen yoder valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign style margin margin bottom border bottom solid font size font family time roman john rydzewski style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign name valign bottom nbsp nbsp valign stephen yoder valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign name valign bottom nbsp nbsp valign john rydzewski style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign title valign bottom nbsp nbsp valign president valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign title valign bottom nbsp nbsp valign executive chairman board style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign date valign bottom nbsp nbsp valign april valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign date valign bottom nbsp nbsp valign april style font size height colspan height colspan height colspan height colspan style font family time roman font size valign colspan pieris pharmaceutical gmbh valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom nbsp nbsp valign style margin margin bottom border bottom solid font size font family time roman stephen yoder valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign name valign bottom nbsp nbsp valign stephen yoder valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign title valign bottom nbsp nbsp valign president valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign date valign bottom nbsp nbsp valign nbsp april valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center portion exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule security exchange amended style margin margin bottom font size font family time roman align center page style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center patent right effective date style margin margin bottom font size font family time roman subject matter that pertains first antibody claim example subject matter that would apply different antibody even contained same claim following patent application style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign bottom nowrap style margin margin bottom border bottom solid width font size font family time roman patent nbsp application nbsp valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom border bottom solid width font size font family time roman filing nbsp date style font size height height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman page valign bottom nbsp nbsp nbsp nbsp valign bottom table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center portion exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule security exchange amended style margin margin bottom font size font family time roman align center page style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center first antibody description style margin margin bottom font size font family time roman align center page style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center portion exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule security exchange amended style margin margin bottom font size font family time roman align center page style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center subsequent antibody description style margin margin bottom font size font family time roman align center completed with definitive agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center portion exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule security exchange amended style margin margin bottom font size font family time roman align center page style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center pieris enumeral form filing style margin margin bottom font size font family time roman pieris form disclosure style margin margin bottom font size font family time roman april nbsp pieris pharmaceutical company pieris pharmaceutical gmbh wholly owned subsidiary company together with company pieris entered into license transfer agreement agreement with enumeral biomedical holding enumeral pursuant which pieris acquired exclusive except exclusive field described below worldwide license specified patent right know owned enumeral research develop market fusion protein consisting antibody linked more anticalin protein oncology area enumeral also agreed practice assist third party practicing exclusive field consisting licensed antibody fused anticalin protein oncology area style margin margin bottom font size font family time roman under agreement pieris agreed enumeral upfront license nbsp maintenance nbsp under initial license pieris also agreed enumeral development milestone aggregate million product indication sale milestone aggregate million product indication nbsp pieris also agreed enumeral royalty within range lower middle single digit percentage sale depending amount sale applicable year nbsp event that pieris required license royalty third party related licensed product royalty payment enumeral shall reduced amount such third party payment royalty payment each calendar year enumeral style margin margin bottom font size font family time roman under agreement pieris option twelve month after date agreement license from enumeral specified antibody owned enumeral developing such fusion anticalin protein oncology area pieris license additional antibody pursuant option described above pieris must enumeral additional undisclosed upfront payment resulting fusion protein product will subject additional royalty development sale milestone same amount applicable fusion protein linking anticalins under initial license style margin margin bottom font size font family time roman term agreement upon expiration last expire patent covered under license nbsp agreement terminated pieris notice enumeral upon notice material breach pieris with respect breach payment obligation pieris provided that pieris cured such breach dispute resolution procedure specified agreement have been followed agreement will also automatically terminate pieris elect make maintenance payment described above style margin margin bottom font size font family time roman foregoing description agreement purport complete qualified entirety reference agreement which pieris intends file exhibit quarterly report form quarter ended march nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center portion exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule security exchange amended style margin margin bottom font size font family time roman align center page style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman enumeral form disclosure style margin margin bottom font size font family time roman april nbsp enumeral biomedical holding with subsidiary enumeral company entered into license transfer agreement agreement with pieris pharmaceutical pieris pharmaceutical gmbh collectively pieris pursuant term agreement enumeral granting pieris exclusive royalty bearing worldwide license specified enumeral patent right know research develop market fusion protein consisting enumeral family anti antibody linked more pieris anticalin protein oncology area enumeral agreed practice assist third party practicing exclusive field consisting licensed antibody fused anticalin protein oncology area style margin margin bottom font size font family time roman pursuant agreement pieris agreed enumeral upfront initial license agreement also provides that pieris option continue license paying enumeral additional maintenance amount nbsp event that pieris this maintenance nbsp agreement expires license granted thereunder automatically terminates style margin margin bottom font size font family time roman pieris elect continue license enumeral maintenance agreement provides that pieris shall also receive option twelve month following date agreement license from enumeral specified antibody owned enumeral same term condition enumeral family anti antibody subsequent option event that pieris exercise subsequent option pieris will enumeral additional undisclosed license style margin margin bottom font size font family time roman term agreement provide pieris enumeral development milestone aggregate million upon achievement specified event well sale milestone payment aggregate million upon achievement specified sale threshold nbsp pieris also agrees enumeral royalty lower middle single digit percentage sale depending amount sale applicable year nbsp event that pieris required license royalty third party related licensed product royalty payment enumeral shall reduced amount such third party payment royalty payment each calendar year enumeral style margin margin bottom font size font family time roman agreement also provides that event pieris license additional antibody pursuant subsequent option resulting fusion protein product will subject additional royalty development sale milestone same amount applicable fusion protein linking anticalins under initial license style margin margin bottom font size font family time roman pursuant term agreement enumeral will indemnify pieris indemnitees defined agreement against certain claim specified therein including with respect breach representation warranty well claim massachusetts institute technology other specified entity party agreement with enumeral addition pieris style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center portion exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule security exchange amended style margin margin bottom font size font family time roman align center page style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman will indemnify enumeral indemnitees defined agreement against certain claim specified therein including with respect breach representation warranty well with respect development commercialization manufacture product before after marketing authorization such term defined agreement agreement also contains customary representation warranty both enumeral pieris style margin margin bottom font size font family time roman term agreement upon expiration last expire patent covered under license nbsp agreement terminated pieris notice enumeral upon notice material breach pieris with respect breach payment obligation pieris provided that pieris cured such breach that dispute resolution procedure specified agreement have been followed agreement will also automatically terminate pieris elect make maintenance payment described above style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center portion exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule security exchange amended style margin margin bottom font size font family time roman align center page style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center enumeral press release style margin margin bottom font size font family time roman align center enumeral pieris pharmaceutical enter into style margin margin bottom font size font family time roman align center license transfer agreement style margin margin bottom font size font family time roman cambridge mass april enumeral biomedical holding otcqb enum enumeral company biotechnology company focused discovering developing novel antibody based immunotherapy help immune system fight cancer other disease today announced that entered into license transfer agreement license agreement with pieris pharmaceutical pieris pharmaceutical gmbh collectively pieris style margin margin bottom font size font family time roman pursuant term condition license agreement pieris licensing from enumeral specified intellectual property related enumeral anti antibody program enum potential development commercialization pieris novel multispecific therapeutic protein comprising fusion protein based pieris anticalins style font size vertical align class therapeutic protein enumeral antibody field oncology style margin margin bottom font size font family time roman under license agreement pieris agreed enumeral initial license enumeral providing pieris with sequence related information enumeral family anti antibody license agreement provides that pieris continue license paying enumeral additional maintenance amount nbsp event that pieris this maintenance nbsp license agreement expires license granted thereunder automatically terminates style margin margin bottom font size font family time roman pieris elect continue license enumeral maintenance license agreement provides that pieris shall also receive exclusive twelve month option license enumeral intellectual property related additional antibody program same term condition enum family anti antibody subsequent option antibody subject subsequent option will selected pieris from specified list antibody owned enumeral event that pieris exercise subsequent option pieris will enumeral additional undisclosed license style margin margin bottom font size font family time roman term license agreement provide pieris enumeral development milestone aggregate million upon achievement specified event well sale milestone payment aggregate million upon achievement specified sale threshold under license agreement pieris also agrees enumeral royalty lower middle single digit percentage sale depending amount sale applicable year event that pieris license additional antibody pursuant subsequent option resulting fusion protein product will subject same royalty development sale milestone applicable fusion protein linking anticalins under initial license style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center portion exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule security exchange amended style margin margin bottom font size font family time roman align center page style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman excited that pieris decided work with antibody sequence encouraged that these sequence could become part novel class therapeutic based pieris anticalin platform said cokey nguyen enumeral vice president research development enumeral been able generate antibody using proprietary platform technology very efficient manner this transaction further validation enumeral approach look forward working with pieris pursue mutual interest under license agreement style margin margin bottom font size font family time roman gaining access enumeral valuable antibody only enables pieris leverage antibody anticalin multispecifics capability with cornerstone immune checkpoint inhibitor also brings high level intra pipeline synergy including with pieris lead bispecific immune costimulator candidate commented pieris president stephen yoder this license give pieris opportunity independently develop anti antibody anticalin multispecific immune checkpoint inhibitor next generation cancer immunotherapeutics style margin margin bottom font size font family time roman about enumeral style margin margin bottom font size font family time roman enumeral biopharmaceutical company discovering developing novel antibody immunotherapy that help immune system fight cancer other disease company building pipeline focused next generation checkpoint modulators with initial target including vista developing these agent enumeral researcher apply proprietary immune profiling technology platform that measure functioning human immune system level individual cell providing insight candidate selection validation more information enumeral please visit enumeral style margin margin bottom font size font family time roman about pieris style margin margin bottom font size font family time roman pieris pharmaceutical clinical stage biotechnology company that discovers develops anticalin based drug target validated disease pathway unique transformative nbsp pieris pipeline includes immuno oncology multi specific tailored tumor micro environment inhaled anticalin treat uncontrolled asthma half life optimized anticalin treat anemia proprietary pieris anticalins novel class protein therapeutic validated clinic partnership with leading pharmaceutical company nbsp anticalin style font size vertical align anticalins style font size vertical align registered trademark pieris more information visit nbsp pieris style margin margin bottom font size font family time roman forward looking statement disclosure style margin margin bottom font size font family time roman this press release contains certain forward looking statement within meaning private security litigation reform amended such statement reflect current belief enumeral biomedical holding enumeral with respect future event involve known unknown risk uncertainty other factor affecting operation market growth enumeral stock price service product license assurance given regarding achievement future result although enumeral belief that expectation reflected these forward looking statement based reasonable assumption style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center portion exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule security exchange amended style margin margin bottom font size font family time roman align center page style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman actual result differ from assumption underlying statement that have been made regarding anticipated event factor that cause actual result performance achievement industry result differ materially from those contemplated such forward looking statement include among others risk that nbsp enumeral expectation regarding market acceptance company business general company ability penetrate antibody discovery development field particular well timing such acceptance nbsp enumeral ability attract retain management with experience biotechnology antibody discovery similar emerging technology nbsp scope validity enforceability enumeral third party intellectual property right nbsp enumeral ability raise capital when needed acceptable term condition nbsp enumeral ability comply with governmental regulation nbsp intensity competition nbsp change political regulatory environment business fiscal condition united state overseas nbsp general economic condition style margin margin bottom font size font family time roman more detailed information about enumeral risk factor that affect realization forward looking statement including forward looking statement this press release forth enumeral filing with security exchange commission enumeral urge investor security holder read those document free charge commission website http forward looking statement speak only date they made except obligation under federal security enumeral undertakes obligation publicly update forward looking statement result information future event otherwise style margin margin bottom font size font family time roman contact style margin margin bottom font size font family time roman enumeral biomedical holding style margin margin bottom font size font family time roman kevin sarney nbsp style margin margin bottom font size font family time roman kevin enumeral style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center portion exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule security exchange amended style margin margin bottom font size font family time roman align center page body html text document